Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering. This report will provide valuable data on the state of clinical trials concerning GVHD, addressing trial numbers and enrollment statistics from leading countries worldwide.
Tue, 14 May 2024 17:00:00 GMT Launched under the theme: Break Borders, Build Global Horizons ... Send us your press releases to pressrelease.zawya@lseg.com Disclaimer: The contents of this press release was provided from an ...
Sun, 12 May 2024 17:00:00 GMT The trade gathering will host ... a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.rxglobal.com. Disclaimer: ...
Sat, 11 May 2024 22:31:13 GMT For many Ugandans who keep track of current affairs and read stories about corruption in their country, the alleged theft by Cabinet ministers of iron sheets belonging to the people of Karamoja, ...
Wed, 08 May 2024 17:00:00 GMT Vascular graft market size was valued at $4,993.64 million in 2020 ... On the basis of region, North America accounted for a majority of the global vascular grafts market share in 2020, and is ...
Tue, 07 May 2024 13:16:00 GMT NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Global Net Lease, Inc. (NYSE ... Forward-Looking Statements The statements in this press release that are not historical facts may be forward-looking ...
